Jim Simons acquired 685 Thousand Myriad Genetics shares worth $2.66 Million. That's 0.00% of their equity portfolio (1655th largest holding). The first Myriad Genetics trade was made in Q2 2013. Since then Jim Simons bought shares 21 more times and sold shares on sixteen occasions. The investor's estimated purchase price is $15.7 Million, resulting in a loss of 83%.